C000272876 Performance — CapForce IBD 50 ETF
Data updated: 2026-09-21
In the 12 months to Jul 2026 the fund lost a net $5.9M, and assets reached $79.53M.
C000272876 Growth of $100
What $100 invested in CapForce IBD 50 ETF grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Mid-Cap Growth category average over the same months.
| Period | C000272876 | Category average |
|---|---|---|
| Since data start (Apr 2026 – Jul 2026) | $111 | $111 |
C000272876 Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +10.87% |
C000272876 Annual Returns
Calendar-year total returns of CapForce IBD 50 ETF, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Apr–Jul) | +10.87% |
C000272876 Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | — | — | — | +14.3% | +7.0% | +7.0% | −15.3% | — | — | — | — | — |
C000272876 Risk
Risk measures from monthly returns over Apr 2026 – Jul 2026.
- Best month: +14.27% (Apr 2026)
- Worst month: −15.29% (Jul 2026)
C000272876 Fund Flows
Monthly money in and out of CapForce IBD 50 ETF, from SEC Form N-PORT.
- 12-month net flow: −$5.9M
- 12-month gross sales (incl. reinvestments): $2.1M
- Sales ÷ redemptions: 0.26×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $0 | $0 | $0 |
| Jun 2026 | $2.1M | $4.0M | −$1.9M |
| May 2026 | $0 | $4.1M | −$4.1M |
| Apr 2026 | $0 | $0 | $0 |
C000272876 Assets Under Management
Net assets of CapForce IBD 50 ETF by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $79.53M |
| 2026-04-30 | $87.69M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.